One of our customers spent the better part of two years going back to his GP with the same symptoms: persistent bloating, nausea, and digestive discomfort that never quite went away. Each time, he was prescribed a proton pump inhibitor. The oral tests kept coming back negative. Nobody tested further.
Eventually, a different GP ordered a urea breath test. It came back positive for H. pylori. He went through triple therapy, two weeks of antibiotics and a PPI, and the infection cleared. But his gut, understandably, was in a poor state.
His story isn’t unusual. H. pylori is notoriously difficult to detect with certain tests, and PPIs manage symptoms without addressing the underlying infection. Many people go through exactly this cycle before getting the right diagnosis. Once they do, and once eradication therapy works, the question becomes: what next?
What Triple Therapy Does to Your Gut
H. pylori eradication typically involves two antibiotics, usually clarithromycin and amoxicillin, alongside a proton pump inhibitor taken for 7 to 14 days. It works well for most people. But antibiotics don’t discriminate between H. pylori and the hundreds of other bacterial species that make up a healthy gut microbiome.
Studies using 16S rRNA sequencing have tracked what happens. In the first two weeks after treatment, the gut shifts towards Proteobacteria dominance, while the more familiar Firmicutes and Bacteroidetes drop sharply. Alpha diversity, a measure of microbial richness, falls significantly (p<0.01).
Recovery is faster than older antibiotic literature suggested. Diversity typically returns to near-baseline by around week 8, in both people who took probiotics and those who didn’t. Full functional recovery, meaning the metabolic activities the microbiome carries out, takes longer, generally several months. Salivary microbiota also shifts during treatment, with Neisseria rising and Streptococcus dropping.
This isn’t a reason to avoid triple therapy. H. pylori left untreated carries real risks, including gastric ulcers, chronic gastritis, and elevated long-term gastric cancer risk. But it does mean recovery doesn’t end when the antibiotic course does.
What the Research Shows on Probiotics During and After Treatment
A series of randomised controlled trials have examined whether probiotics help during and after H. pylori eradication. The findings are reasonably consistent.
Side effects. A 2022 RCT (n=120) found GI adverse events in 23.6% of those taking probiotics during treatment, compared with 37.7% on placebo (p=0.016). Bloating and diarrhoea were the symptoms most commonly reduced.
Treatment adherence. Participants who took probiotics alongside antibiotics were more likely to complete the full course (91.7% vs 83.3%, p=0.038). This matters because incomplete eradication therapy is one of the main drivers of antibiotic resistance and treatment failure.
Reinfection at 12 months. A 2025 study using propensity score matching (n=240) found 12-month reinfection rates of 9.2% in the probiotics group versus 19.2% in controls (p=0.021), roughly a halving of recurrence. UK reinfection rates in the general adult population tend to run lower than this study cohort, but the relative direction of effect is consistent with the wider literature.
Eradication rate. Probiotics do not appear to change whether the antibiotic course itself successfully clears the infection. The recent evidence shows no significant difference in eradication rates between probiotic and placebo arms.
The honest summary: probiotics don’t prevent dysbiosis, but the evidence suggests they make recovery smoother, reduce side effects, improve adherence, and may lower 12-month reinfection risk.
Which Strains the Research Has Examined
Multi-strain Lactobacillus and Bifidobacterium combinations are the most studied in the post-H. pylori context. Research suggests multi-strain preparations outperform single-strain products, likely because different strains occupy different niches and serve different functional roles. Functional pathway analysis from one of the RCTs above showed multi-strain probiotic groups had higher cofactor and vitamin metabolism activity and lower lipopolysaccharide biosynthesis, a marker associated with pathogenic gram-negative bacteria.
Within this category, Lactobacillus rhamnosus GG has been examined for its role in reducing antibiotic-associated diarrhoea. Lactobacillus casei and Lactobacillus plantarum have been studied in the context of immune balance, which is relevant because H. pylori infection triggers a chronic inflammatory response that doesn’t always resolve immediately after eradication.
Saccharomyces boulardii deserves separate mention. It’s a yeast rather than a bacterium, and that distinction matters practically. Being a yeast, it’s naturally resistant to antibiotics, so it can be taken during the course itself without the 2-hour spacing that bacterial probiotics require. It also has the strongest individual evidence base of any single strain for reducing antibiotic-associated diarrhoea (Szajewska et al., 2010, in Alimentary Pharmacology & Therapeutics), and it’s been used in H. pylori protocols for decades specifically because of this profile. The most recent evidence does not show that S. boulardii or any other probiotic improves eradication rates themselves, but its role in side-effect reduction during treatment is well established. It complements multi-strain bacterial probiotics rather than replacing them.
What to Look for in a Post-Treatment Probiotic
Based on the research:
- A multi-strain formulation rather than a single-strain product
- Both Lactobacillus and Bifidobacterium represented
- Saccharomyces boulardii alongside the bacterial strains, particularly if you want a probiotic you can start during the antibiotic course without timing constraints
- A standard clinical dose, generally 10⁹ to 10¹⁰ CFU per day
- Live, active cultures where available, rather than freeze-dried organisms that need to rehydrate in the gut
Biome Bliss contains Saccharomyces boulardii, Lactobacillus rhamnosus, Lactobacillus casei, Lactobacillus plantarum, Streptococcus thermophilus, and Propionibacterium freudenreichii. It’s a live fermented liquid format, with six complementary strains spanning the bacterial and yeast categories most studied in this context. For more detail on what each strain does, see our guide to the probiotic strains in Biome Bliss.
Timing and Duration
The most consistent protocol across the research:
- Start during the antibiotic course. Bacterial strains spaced at least 2 hours from antibiotic doses. S. boulardii doesn’t need spacing.
- Continue for 4 to 8 weeks after finishing antibiotics. This is the window where diversity is recovering, and continued probiotic intake appears to support that process.
- Beyond 8 weeks, longer-term use is safe and may offer ongoing benefit, particularly if digestive symptoms haven’t fully resolved.
Diet matters alongside any supplement. Fermented foods such as yoghurt, kefir, sauerkraut, and kimchi help reintroduce bacterial diversity. Prebiotic foods (garlic, onion, leeks, oats, bananas) feed the beneficial bacteria trying to re-establish. Increases in Roseburia and Dialister have been associated with successful eradication outcomes, and these are fibre-fermenting bacteria that depend on prebiotic intake. For more on supporting gut health through diet, see our guide to improving gut health.
A Note on PPIs and H. pylori Diagnosis
Our customer’s experience, years on PPIs with repeatedly negative tests, reflects a genuine diagnostic challenge. PPIs suppress bacterial activity enough to reduce the sensitivity of stool antigen and breath tests, producing false negatives. Blood tests detect antibodies rather than active infection and can also mislead.
If you’ve been symptomatic and repeatedly tested negative while on a PPI, a urea breath test taken at least two weeks after stopping the PPI (and four weeks after any antibiotics) is the most accurate non-invasive test available. It’s worth raising this specifically with your GP if your symptoms haven’t been adequately explained.
FAQ
Q: Should I take probiotics after H. pylori treatment?
A: The research supports it. Probiotics taken during and after triple therapy have been shown to reduce GI side effects (23.6% vs 37.7%), improve adherence to the antibiotic course (91.7% vs 83.3%), and lower 12-month reinfection risk by roughly half. They don’t change whether eradication itself succeeds, but they appear to make recovery smoother.
Q: How long does it take for gut bacteria to recover after H. pylori treatment?
A: Microbial diversity typically returns to near-baseline by around week 8. Full functional recovery, meaning the metabolic activities the microbiome carries out, takes longer, generally several months. Probiotics during and after treatment appear to reduce the magnitude of disruption rather than dramatically accelerate the timeline.
Q: What are the best probiotics to take after H. pylori treatment?
A: A multi-strain product combining Lactobacillus and Bifidobacterium has the most consistent evidence in the post-eradication context. Saccharomyces boulardii, a yeast strain, has strong evidence for reducing antibiotic-associated diarrhoea and can be taken during the antibiotic course without 2-hour spacing. A formulation containing both is well aligned with the research.
Q: Can H. pylori come back after successful treatment?
A: Yes. Studies report 12-month reinfection rates of around 19% in placebo groups and 9% in those who took probiotics, with UK rates in the general adult population tending to be lower than this. Maintaining a diverse, healthy microbiome and probiotic supplementation both appear to reduce recurrence risk, though they don’t eliminate it. Hand hygiene and food safety practices reduce transmission risk further.
Q: My GP kept prescribing PPIs and my tests were negative, could I still have had H. pylori?
A: Possibly. PPIs suppress bacterial activity and can reduce the sensitivity of stool antigen tests and urea breath tests, producing false negatives. If you’ve been symptomatic and tests have come back negative while on a PPI, ask your GP about a urea breath test taken at least two weeks after stopping the PPI.
References
- Randomised controlled trial (2022, n=120) on probiotic modulation of gastric, salivary, and gut microbiota during and after H. pylori eradication therapy.
- Randomised controlled trial (2021, n=60) on probiotic supplementation after H. pylori eradication, including alpha diversity and functional pathway analysis.
- Propensity score matched study (Frontiers in Pharmacology, 2025, n=240) on probiotic supplementation and 12-month H. pylori reinfection.
- Szajewska H, et al. (2010). Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects. Alimentary Pharmacology & Therapeutics, 32(9), 1069–1079.
- NHS. Helicobacter pylori.
This article is for informational purposes only and does not constitute medical advice. If you have symptoms that may indicate H. pylori infection, speak to your GP for appropriate testing and treatment.
